Ultra-high pressure liquid chromatography coupled to travelling wave ion mobility-time of flight mass spectrometry for the screening of pharmaceutical metabolites in wastewater samples: Application to antiretrovirals

• Published in: Journal of Chromatography A Vol. 1660; p. 462650
• Main Authors: Mosekiemang, Tlou T., Stander, Maria A., de Villiers, André
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 20.12.2021
• Subjects: Antiretrovirals; Chromatography, High Pressure Liquid; HIV Infections; Humans; Ion Mobility Spectrometry; Mass defect filtering; Mass Spectrometry; Metabolites; Pharmaceutical Preparations; Waste Water; Wastewater; Mass defect filtering; Antiretrovirals; Ion mobility spectrometry; Metabolites; Wastewater
• ISSN: 0021-9673; 1873-3778
• DOI: 10.1016/j.chroma.2021.462650

•UHPLC-IMS-HR-MS method for detection of antiretroviral metabolites in wastewater.•Mass defect filter template implemented to detect phase I and phase II metabolites.•IMS-filtered data improves data visualisation and spectral quality.•Collisional cross sections (CCS) for antiretroviral drugs and metabolites reported.•9 antiretroviral metabolites tentatively identified in wastewater for the first time. The presence of pharmaceutical compounds in the aquatic environment is a significant environmental health concern, which is exacerbated by recent evidence of the contribution of drug metabolites to the overall pharmaceutical load. In light of a recent report of the occurrence of metabolites of antiretroviral drugs (ARVDs) in wastewater, we investigate in the present work the occurrence of further ARVD metabolites in samples obtained from a domestic wastewater treatment plant in the Western Cape, South Africa. Pharmacokinetic data indicate that ARVDs are biotransformed into several positional isomeric metabolites, only two of which have been reported wastewater samples. Given the challenges associated with the separation and identification of isomeric species in complex wastewater samples, a method based on liquid chromatography hyphenated to ion mobility spectrometry-high resolution mass spectrometry (LC-IMS-HR-MS) was implemented. Gradient LC separation was achieved on a sub-2 µm reversed phase column, while the quadrupole-time-of-flight MS was operated in data independent acquisition (DIA) mode to increase spectral coverage of detected features. A mass defect filter (MDF) template was implemented to detect ARVD metabolites with known phase I and phase II mass shifts and fractional mass differences and to filter out potential interferents. IMS proved particularly useful in filtering the MS data for co-eluting species according to arrival time to provide cleaner mass spectra. This approach allowed us to confirm the presence of two known hydroxylated efavirenz and nevirapine metabolites using authentic standards, and to tentatively identify a carboxylate metabolite of abacavir previously reported in literature. Furthermore, three hydroxylated-, two sulphated and one glucuronidated metabolite of efavirenz, two hydroxylated metabolites of nevirapine and one hydroxylated metabolite of ritonavir were tentatively or putatively identified in wastewater samples for the first time. Assignment of the metabolites is discussed in terms of high resolution fragmentation data, while collisional cross section (CCS) values measured for the detected analytes are reported to facilitate further work in this area.